News

Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion ...
8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High ...
26 June 2025 Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal ...
17 June 2025 Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving ...
French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient ...
This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy ...